Clinical Trial Update: Study of Endostar Combined With TP Regimen for Esophageal Cancer [Phase 4]

View source ↗

Summary

Phase 4 trial update on Endostar combined with TP regimen for esophageal cancer (II-III stage) is in an unknown status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Cancer

Drugs mentioned

• Endostar (recombinant human endostatin)
• TP regimen

Snippet

Sponsor: Second Affiliated Hospital of Xi'an Jiaotong University | Conditions: Patients With Esophageal Cancer(Ⅱ-Ⅲ) | Phase 4 | Status: UNKNOWN